Emory Healthcare, Georgia’s largest academic health system, has joined several other large academic medical centers that are partnering with software company nference to advance the generation of real-world evidence.
Cambridge, Massachusetts-based Nference said its proprietary AI-enabled software platform, nSights, has been used to accelerate research, development and clinical care in life sciences, including biomarker discovery and validation, generation of real-world evidence leveraging real-world data. early detection of diseases, generation and validation of public health policies, and more.
The nSights platform provides a 360-degree longitudinal view of each patient by leveraging a suite of biomedical information, such as electronic medical records, electrocardiograms, radiology images, and more. Future iterations will also include digital pathology and genomics.
Previously, Mayo Clinic, Duke Health and Vanderbilt University Medical Center announced partnerships with nference. The partnership with Mayo Clinic provides nference partners and customers with access to de-identified electronic health data from the Mayo Clinic Platform across a variety of diseases and therapeutic areas. The collaboration is establishing a Mayo Clinic-branded version of nSights, called Mayo Clinic Platform Discover, created and supported by nference.
Emory Healthcare is comprised of 11 hospitals, the Emory Clinic and more than 250 provider locations. Its collaboration with nference will support research in multiple therapeutic areas and expand nference’s federated data network with diverse, multimodal (clinical and imaging) data for real-world evidence research and AI model development. The platform, launched in September 2022, enables scientists and clinicians to transform discovery and accelerate development by creating highly targeted cohorts for large-scale research, while preserving patient privacy.
Emory Healthcare will leverage nference’s capabilities to securely anonymize health information and provide the health system with information about diseases, treatments and patient outcomes. “At Emory Healthcare, we are committed to research excellence and recognize the importance of real-world evidence to address unmet needs in patient populations,” said Joe Depa, chief data and analytics officer at Emory Healthcare and Emory University. , it’s a statement. “This collaboration with nference allows us to join a federated data network of leading institutions that will enable innovative research. “Together, we can work to improve lives and provide hope, addressing some of the most critical healthcare challenges of our time while providing comprehensive, data-driven insights.”
Depa recently joined Emory from Accenture, where he served as senior managing director and global data and artificial intelligence leader for the company’s strategy and consulting business.
“As we continue to advance deep collaborations with the world’s best academic medical centers, our multimodal AI platform will enable the discovery of life-saving medications, advance the development of next-generation interventions, and transform clinical practice through digitization on an unprecedented scale. ”said Murali Aravamudan, co-founder and CEO of nference, in a statement.
